Eisai is in the midst of an important launch of a new product in the U.S. focused on educating HCPs on a treatment for appropriate individuals suffering from mild cognitive impairment due to Alzheimer's disease (AD) or mild AD. The Neurology Account Account Specialist, Field, Neuro, Business Operations, Healthcare, Specialist